<?xml version="1.0" encoding="UTF-8"?>
<p>These results corroborate with the study by Formiga 
 <italic>et al</italic>[
 <xref rid="B52" ref-type="bibr">52</xref>] with the ethanolic extract of 
 <italic>Maytenus erythroxylon </italic>Reissek, which has triterpenes in its composition, the administration of the extract associated with propranolol, L-NAME or glibenclamide reduced its antimotility effect, suggesting the participation of adrenergic and nitrergic pathways and K
 <sub>ATP</sub> channels in their effect.
</p>
